Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature.
Saved in:
| Title: | Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature. |
|---|---|
| Authors: | Murteira S; Equipe Santé, Individu, Société-EA 4128, University of Lyon, Lyon, France; Lundbeck SAS, 37-45, Quai du Président Roosevelt, 92445 Issy-les-Moulineaux, Cedex, Paris, France., Ghezaiel Z; Creativ-Ceutical S.A., 215, rue du Faubourg St-Honoré 75008 Paris, France., Karray S; Creativ-Ceutical S.A., 215, rue du Faubourg St-Honoré 75008 Paris, France., Lamure M; Equipe Santé, Individu, Société-EA 4128, University of Lyon, Lyon, France. |
| Source: | Journal of market access & health policy [J Mark Access Health Policy] 2013 Aug 06; Vol. 1. Date of Electronic Publication: 2013 Aug 06 (Print Publication: 2013). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101670174 Publication Model: eCollection Cited Medium: Print ISSN: 2001-6689 (Print) Linking ISSN: 20016689 NLM ISO Abbreviation: J Mark Access Health Policy Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
